arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

download Export Data

Immunovant, Inc.

IMVT

$28.39 ▼ -1.50 (-5.03%) at close

34 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Immunovant, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.8B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC —

FCF / Share $-0.61

Trailing P/E —

Price / Book 8.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

34-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-153.22M

↓ -27.0% —

FCF / Share Free cash flow per share

$-0.61

↑ +11.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
EPS Growth YoY (%)	-5.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	19.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	1.4% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-18.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-21.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-111.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-64.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.6% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	26.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-9.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-62.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-36.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-17.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-12.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-46.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-12.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-40.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-27.0% Weak ↑ Weak Improving Year-over-year change in net income	-38.9% Weak → Weak Stable Year-over-year change in net income	-38.4% Weak → Weak Stable Year-over-year change in net income	-38.4% Weak ↓ Weak Declining Year-over-year change in net income	-38.4% Weak ↓ Weak Declining Year-over-year change in net income	-41.3% Weak ↓ Weak Declining Year-over-year change in net income	-17.9% Weak ↑ Weak Improving Year-over-year change in net income	-17.9% Weak ↑ Weak Improving Year-over-year change in net income	-17.9% Weak ↑ Weak Improving Year-over-year change in net income	-26.7% Weak ↑ Weak Improving Year-over-year change in net income	-83.1% Weak ↓ Weak Declining Year-over-year change in net income	-83.1% Weak ↓ Weak Declining Year-over-year change in net income	-83.1% Weak ↓ Weak Declining Year-over-year change in net income	-26.0% Weak ↑ Weak Improving Year-over-year change in net income	-32.5% Weak ↑ Weak Improving Year-over-year change in net income	-32.5% Weak ↑ Weak Improving Year-over-year change in net income	-32.5% Weak → Weak Stable Year-over-year change in net income	-67.5% Weak ↓ Weak Declining Year-over-year change in net income	-14.1% Weak ↑ Weak Improving Year-over-year change in net income	-14.1% Weak ↑ Weak Improving Year-over-year change in net income	-14.1% Weak ↑ Weak Improving Year-over-year change in net income	-37.0% Weak ↓ Weak Declining Year-over-year change in net income	-33.1% Weak ↑ Weak Improving Year-over-year change in net income	-33.1% Weak ↑ Weak Improving Year-over-year change in net income	-33.1% Weak ↑ Weak Improving Year-over-year change in net income	-127.5% Weak ↑ Weak Improving Year-over-year change in net income	-4457455.6% Weak Weak Year-over-year change in net income	—	-4457455.6% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	11.9% Fair Fair Year-over-year change in free cash flow	—	—	—	-31.4% Weak Weak Year-over-year change in free cash flow	—	—	—	-43.9% Weak Weak Year-over-year change in free cash flow	—	—	—	35.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-160.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.63x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.40x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 2 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Return on Capital (%) (%)	—	—	—	—	—	—	—	—	—	—	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-9.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-20.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-17.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-12.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-23.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-255%)	-19.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	-15.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-24.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-19.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	-16.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-12.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-10.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-29.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-24.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-264%)	-16.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-9.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-10.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-9.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-6.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-5.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-8.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-7.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-21.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	-17.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	86.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+474%)	165.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1004%)	-123.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-920%)	-1.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Net Debt (USD)	$-797.80M	$-902.11M	$-994.52M	$-521.87M	$-598.91M	$-713.97M	$-374.69M	$-472.94M	$-560.00M	—	$-690.94M	$-269.93M	$-329.96M	—	$-432.61M	$-405.77M	$-427.20M	$-493.82M	$-527.00M	$-558.95M	$-379.00M	$-400.15M	—	—	$-280.28M	$-100.57M	$-123.53M	—	—	$-6.99M	$-325.00K	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.75	$-0.73	$-0.61	$-0.73	$-0.71	$-0.63	$-0.76	$-0.74	$-0.60	$-0.52	$-0.36	$-0.45	$-0.57	$-0.45	$-0.49	$-0.41	$-0.35	$-0.41	$-0.36	$-0.35	$-0.31	$-0.28	$-0.32	$-0.25	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.61	—	$-0.51	$-0.59	$-0.69	—	—	—	$-0.52	—	—	—	$-0.36	—	—	—	$-0.57	—	—	—	$-0.22	—	$-0.23	$-0.29	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.57	$4.18	$4.85	$2.98	$3.56	$4.16	$2.40	$3.06	$3.73	—	$4.68	$1.92	$2.30	—	$3.21	$3.39	$3.75	$4.03	$4.39	$4.66	$3.73	$4.00	$4.23	$5.20	$3.31	$1.72	$2.05	—	—	$0.19	$0.01	—	—	—
Tangible Book Value per Share (USD)	$3.57	$4.18	$4.85	$2.98	$3.56	$4.16	$2.40	$3.06	$3.73	—	$4.68	$1.92	$2.30	—	$3.21	$3.39	$3.75	$4.03	$4.39	$4.66	$3.73	$4.00	$4.23	$5.20	$3.31	$1.72	$2.05	—	—	$0.19	$0.01	—	—	—
Basic Weighted Avg Shares (shares)	205.55M	—	181.51M	173.64M	170.87M	—	146.92M	146.47M	146.09M	—	144.52M	131.16M	130.50M	—	128.57M	116.57M	116.56M	—	115.03M	109.08M	97.98M	—	97.92M	84.35M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Working Capital (USD)	$734.08M	$844.40M	$976.68M	$510.29M	$598.86M	$698.89M	$344.23M	$440.72M	$544.03M	—	$678.67M	$250.92M	$298.66M	—	$413.16M	$394.31M	$435.06M	$468.41M	$504.13M	$535.41M	$364.30M	$390.24M	—	—	$266.57M	$93.76M	—	—	—	—	$-55.45K	—	—	—
Total Equity (USD)	$735.39M	$852.59M	$986.13M	$519.71M	$608.54M	$707.45M	$352.62M	$449.05M	$544.66M	$617.76M	$679.34M	$251.81M	$299.87M	$362.49M	$414.68M	$395.75M	$436.49M	$469.82M	$505.15M	$536.40M	$365.53M	$391.48M	$414.15M	$438.41M	$267.77M	$94.07M	$111.86M	$-23.28M	$-12.11M	$7.34M	$24.55K	$2.32M	—	$-1.50M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q3 FY2019 Mar 31, 2019 10-Q ↗	Q2 FY2019 Sep 30, 2018 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Depreciation Expense (USD)	$92.00K	$96.00K	$101.00K	$105.00K	$107.00K	$109.00K	—	—	$80.00K	$64.00K	—	—	$53.00K	$54.00K	—	—	$44.00K	$39.00K	—	—	$26.00K	$22.00K	$19.00K	$14.00K	$10.00K	$6.00K	—	$5.00K	$5.00K	$5.00K	—	—	—	—
Net Income, GAAP (USD)	$-153.22M	$-147.86M	$-120.61M	$-120.61M	$-120.61M	$-106.45M	$-87.15M	$-87.15M	$-87.15M	$-75.32M	$-73.94M	$-73.94M	$-73.94M	$-59.43M	$-40.37M	$-40.37M	$-40.37M	$-47.17M	$-30.47M	$-30.47M	$-30.47M	$-28.16M	$-26.71M	$-26.71M	$-26.71M	$-20.55M	$-20.06M	$-20.06M	$-20.06M	$-9.03M	$-450.00	—	$-450.00	—
Operating Cash Flow (USD)	$-124.41M	$-95.06M	$-92.33M	$-102.52M	$-117.41M	$-110.64M	—	—	$-76.20M	$-59.70M	—	—	$-47.37M	$-55.79M	—	—	$-65.82M	$-32.96M	—	—	$-21.21M	$-22.50M	$-22.82M	$-24.22M	$-13.80M	$-23.05M	—	$-17.56M	$-8.33M	$-12.65M	—	—	$-450.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 34 quarters

Immunovant, Inc.

Analytical Summary

34-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IMVT with peers